2 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Terminated 2, Not yet recruiting 1, Recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Methyltestosterone: new trials by email Literature Review of Methyltestosterone trials Research Report on Methyltestosterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study Biopsy Procedure, Biospecimen Collection, Bone Scan - Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma | Phase 2 | Recruiting | University of Washington | 69 | 2024-05-21 | 2026-07-21 |
| Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes Esterified Estrogens (EE) and Methyltestosterone (MT) - Hot Flushes, Menopause, Postmenopause | Phase 2 | Completed | Solvay Pharmaceuticals | 1251 | 2005-06-01 | 2008-08-15 |
| The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women esterified estrogens 1.25mg and methyltestosterone 2.5mg, Esterified estrogens 1.25 mg - Menopause | Phase 2 | Terminated | Solvay Pharmaceuticals | 133 | 2004-07-01 | 2008-04-11 |
| The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women esterified estrogens 1.25 mg and methyltestosterone 2.5 mg, Esterified estrogens 1.25 mg - Menopause | Phase 2 | Terminated | Solvay Pharmaceuticals | 28 | 2004-07-01 | 2008-04-11 |
| Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women esterified estrogens 0.625 mg and methyltestosterone 1.25 mg - Menopause | Phase 2 | Completed | Solvay Pharmaceuticals | 350 | 2004-06-01 | 2015-01-16 |
Prostatic Neoplasms (2) · Hot Flashes (1)
Solvay Pharmaceuticals (4) · ECOG-ACRIN Cancer Research Group (1) · University of Washington (1)
United States (5) · Canada (1) · Russia (1)
2005 (1), P50CA097186 (1), U10CA180820 (1)